People: AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

10.67USD
23 May 2013
Price Change (% chg)

$-0.02 (-0.19%)
Prev Close
$10.69
Open
$10.63
Day's High
$10.76
Day's Low
$10.59
Volume
95,486
Avg. Vol
121,401
52-wk High
$12.91
52-wk Low
$9.52

Search Stocks

Bourne, George 

Brief Biography

Mr. George W. Bourne has been appointed as Senior Vice President, Chief Technology & Operations Officer of AngioDynamics, Inc., effective December 17, 2012. Previously Mr. Bourne was Senior Vice President and Chief Technology Officer for the Company, joining in May, 2012. Prior to joining AngioDynamics, Mr. Bourne served as VP of R&D at Hologic, and before this served as Senior Vice President of R&D and Clinical Affairs for Navilyst Medical from its formation in early 2008 until November 2011. His tenure was defined by focused portfolio development and the commercialization of new products. He also served 10 years at Boston Scientific as Vice President, R&D, of the Urology, Meditech and Oncology business units and then as Group Vice President, R&D, for the endosurgery business group. Mr. Bourne earned his Bachelor of Science in Biological Science and Master of Science in Plastics Engineering from the University of Lowell, in addition to his MBA from Rivier College in Nashua, N.H. He also served in leadership positions at Baxter Healthcare, Allegiance Healthcare and C.R. Bard.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Vincent Bucci

15,914

Joseph DeVivo

3,532,210

Mark Frost

--

George Bourne

--

Stephen McGill

496,559

Alan Panzer

1,264,280
As Of 30 May 2012
Search Stocks